₹0.06
(Market cap
₹91 Cr
Revenue (TTM)
₹114 Cr
P/E Ratio
--
P/B Ratio
1.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-1 Cr
-
ROE
1.6 %
-
ROCE
5 %
-
Industry P/E
44.31
-
EV/EBITDA
56.8
-
Debt to Equity
0.2
-
Book Value
₹5.3
-
EPS
₹-0.1
-
Face value
2
-
Shares outstanding
130,462,130
10 Years Aggregate
CFO
₹-9.70 Cr
EBITDA
₹30.95 Cr
Net Profit
₹15.43 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Vaishali Pharma
| -18.9 | -9.8 | -9.6 | -46.2 | -19.3 | 13.6 | -- |
|
BSE Healthcare
| 10.2 | 10.3 | 11.1 | 13.4 | 28.1 | 14.5 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Vaishali Pharma
| -51.6 | -6.2 | 31.2 | 286.8 | -52.3 | 109.1 | 7.1 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Vaishali Pharma
|
7.0 | 91.2 | 114.1 | -0.5 | -2.0 | -0.8 | -- | 1.3 |
| 3,000.4 | 24,554.0 | 1,339.4 | 356.4 | 33.2 | 23.2 | 68.9 | 14.8 | |
| 419.9 | 16,087.0 | 2,268.6 | 150.1 | 10.6 | 5.4 | 89.8 | 4.1 | |
| 764.2 | 18,926.7 | 5,365.6 | 595.0 | 16.6 | 13.3 | 31.8 | 3.7 | |
| 1,011.7 | 16,107.3 | 7,918.4 | 429.9 | 10.7 | 7.2 | 37.2 | 2.4 | |
| 1,174.3 | 21,003.3 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 13.5 | 2.4 | |
| 1,861.8 | 21,346.5 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.7 | |
| 176.1 | 23,381.5 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.9 | |
| 470.2 | 18,982.5 | 3,738.7 | 316.7 | 12.5 | 7.5 | 59.9 | 3.9 | |
| 1,599.8 | 26,016.6 | 3,373.0 | 199.0 | 12.6 | 5.9 | 122.1 | 5.3 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Vaishali Pharma
Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers a portfolio of active pharmaceutical ingredients, such as antibiotics, anti-ulcer, anti-inflammatory, analgesic, anti-pyretic, topical steroids,... anti"malarial, cardiac, corticosteroids, anti-diabetics, anti-cold, anti-allergic, anti-diarrheal, anti-protozoal, anti-parasitic, excipients, anti-viral, anti-epileptic, anti-asthmatic, enzymes, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helminitic. The company also provides formulations, including antibiotics, antibacterial, anti-platelet, laxative, anti-ulcer, enzymes, anti-asthmatic, anti-malarial, anti-cold, anti-allergic, anti-viral, anti-psychotic, anti-fungal, vitamins, topical steroids, corticosteroids, anti-inflammatory, analgesic, anti-pyretic, anti-diabetic, cardiac, and other products. In addition, it offers disposable surgical and casting tape products; herbal products; veterinary products; nutraceutical products; and oncology products. The company was formerly known as Vaishali Pharma Private Limited. Vaishali Pharma Limited was founded in 1989 and is based in Mumbai, India. Read more
-
Incorporated
2008
-
Chairman
--
-
Managing Director
Atul Vasani
-
Headquarters
Mumbai, Maharashtra
-
Website
Looking for more details about Vaishali Pharma Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Announcements
View AnnouncementsFAQs for Vaishali Pharma
What is the current share price of Vaishali Pharma Ltd Today?
The share price of Vaishali Pharma Ltd is ₹6.99 (NSE) as of 21-May-2026 IST. Vaishali Pharma Ltd has given a return of -19.28% in the last 3 years.
What is the current PB & PE ratio of Vaishali Pharma Ltd?
Since, TTM earnings of Vaishali Pharma Ltd is negative, P/E ratio is not available.
The P/B ratio of Vaishali Pharma Ltd is 1.33 times as on 21-May-2026, a 66 discount to its peers’ median range of 3.89 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
200.64
|
2.53
|
|
2024
|
20.88
|
4.19
|
|
2023
|
2.33
|
4.67
|
|
2022
|
17.34
|
2.65
|
|
2021
|
32.86
|
1.53
|
What is the 52 Week High and Low of Vaishali Pharma Ltd?
The 52-week high and low of Vaishali Pharma Ltd are Rs 13.59 and Rs 4.75 as of 21-May-2026.
What is the market cap of Vaishali Pharma Ltd?
Vaishali Pharma Ltd has a market capitalisation of ₹ 91 Cr as on 21-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Vaishali Pharma Ltd?
Before investing in Vaishali Pharma Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.